29.50
2.08%
0.60
Dopo l'orario di chiusura:
29.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Baxter International Inc Borsa (BAX) Ultime notizie
Investors Purchase Large Volume of Baxter International Put Options (NYSE:BAX) - MarketBeat
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter Resumes Production of Peritoneal Dialysis Solutions - DocWire News
Interesting BAX Put And Call Options For August 2025 - Nasdaq
Baxter International Inc. (NYSE:BAX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Baxter stock hits 52-week low at $29.14 amid market challenges - Investing.com Australia
Parenteral Nutrition Market May Set Epic Growth Story | Baxter, Hospira, Pfizer - openPR
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International's SWOT analysis: medical supplies stock faces mixed signals - Investing.com
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter International (NYSE:BAX) Hits New 1-Year LowTime to Sell? - MarketBeat
Toronto Dominion Bank Buys 22,787 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Fresenius Can't Stop Baxter's Effort To Save Dialysis Patent - Law360
Baxter Stock May Gain Following Five New Injectable Product Launches - Yahoo Finance
Geode Capital Management LLC Grows Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Advanced Wound Care Management Market Share to Rise At 5.1% CAGR, To Reach USD 17.50 Billion by 2034 | PMR - GlobeNewswire Inc.
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Baxter launches five injectable pharmaceutical products in US - World Pharmaceutical Frontiers
Tympanometer Market Top Companies StudyDemant Group, Baxter International, Oscilla Hearing, Amplifon SpA. - openPR
Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S. - Business Wire
Empire Financial Management Company LLC Buys 19,500 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter Announces Continued Growth of Pharmaceuticals Portfolio with Five Injectable Product Launches in the U.S. - Baxter
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Oversold Conditions For Baxter International (BAX) - Nasdaq
Is the Options Market Predicting a Spike in Baxter International (BAX) Stock? - MSN
Baxter stock touches 52-week low at $31.6 amid market challenges - Investing.com Canada
José Almeida: 100 Most Influential People in Healthcare 2024 - Modern Healthcare
Adalta Capital Management LLC Sells 16,353 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Drug Delivery Market Overview and Leading Players: Baxter - openPR
Hurricane Pauses IV Production At Baxter's North Carolina Facility - MSN
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter’s Sascha Hanselmann on championing LGBTQ+ inclusion and building authentic workspaces - attitude.co.uk
Disposable Endoscope Market Report 2024 - GlobeNewswire Inc.
Baxter restarts dialysis solutions production at North Cove plant - MSN
Baxter restarts dialysis solutions production at North Cove plant (NYSE:BAX) - Seeking Alpha
Baxter resumes dialysis solution production at its hurricane-hit facility - Reuters
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):